CanSino Gets China's First COVID-19 Vaccine Patent

CanSino Biologics Inc has become the first company to secure a patent for its COVID-19 vaccine in China
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.